|
Revised November 2, 2011 |
||
|
|
||
| ||
|
WAC 182-508-0015 Effective November 1, 2011
| ||
|
WORKER RESPONSIBILITIES
| ||
| ||
|
5. Review DSHS 14-050(X), Statement of Health, Education, and Employment with the person.
6. Explain the purpose, eligibility requirements, and benefits of MCS and Alcoholism and Drug Addiction Treatment and Support Act (ADATSA) programs. 7. Coordinate with a DBHR Chemical Dependency Professional to schedule an assessment when:
| ||
|
CLARIFYING INFORMATION 1. Supplemental Medical Evidence may be used to help better understand the person's incapacities and make well-informed incapacity decisions. Supplemental Medical Evidence does not replace Objective Medical Evidence (OME). OME must still be obtained for the Progressive Evaluation Process. 2. During an ADATSA assessment, the Chemical Dependency Professional (CDP) may suspect that the person has mental health or physical issues that could get in the way of the person participating in ADATSA treatment or that are not related to their addiction. Follow these procedures for handling requests for evaluations from assessment entities: a. The CDP should refer the client back to the CSO to apply for MCS. b. The CSO Case Worker should evaluate the request and consult with the CDP if necessary. The Case Worker should process the MCS application with the appropriate evaluation unless there is a clear and convincing reason otherwise. | ||